Negative CD4+TIM-3 signaling confers resistance against cold preservation damage in mouse liver transplantation

American Journal of Transplantation

Volumn 15, Issue 4, 2015, Pages 954-964

  Liu, Y ^a,b   Ji, H ^a   Zhang, Y ^a,b   Shen, X D ^a   Gao, F ^a   Nguyen, T T ^a   Shang, X ^a   Lee, N ^a   Busuttil, R W ^a   Kupiec Weglinski, J W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

basic (laboratory) research science; immunobiology; innate immunity; ischemia reperfusion injury (IRI); liver transplantation hepatology

Indexed keywords

ALANINE AMINOTRANSFERASE; CD3 ANTIGEN; CD4 ANTIGEN; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; MUCIN; PROGRAMMED DEATH 1 LIGAND 1; RECOMBINANT GALECTIN 9; RECOMBINANT PROTEIN; T CELL IMMUNOGLOBULIN MUCIN 3; UNCLASSIFIED DRUG; HAVCR2 PROTEIN, MOUSE; VIRUS RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CRYOPRESERVATION; GRAFT RECIPIENT; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNOREGULATION; LIVER CELL DAMAGE; LIVER PROTECTION; LIVER SUZUKI HISTOLOGICAL SCORE; LIVER TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PRESERVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SCORING SYSTEM; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; UPREGULATION; ANIMAL; C57BL MOUSE; COLD; IMMUNOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COLD TEMPERATURE; LIVER TRANSPLANTATION; MICE; MICE, INBRED C57BL; RECEPTORS, VIRUS; SIGNAL TRANSDUCTION;

EID: 84925295029     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13067     Document Type: Article

References (33)

1. Wertheim JA, Petrowsky H, Saab S, Kupiec-Weglinski JW, Busuttil RW., Major challenges limiting liver transplantation in the United States. Am J Transplant 2011; 11: 1773-1784.
2. Zhai Y, Petrowsky H, Hong JC, Busuttil RW, Kupiec-Weglinski JW., Ischaemia-reperfusion injury in liver transplantation-From bench to bedside. Nat Rev Gastroenterol Hepatol 2013; 10: 79-89.
3. Zhai Y, Busuttil RW, Kupiec-Weglinski JW., Liver ischemia and reperfusion injury: New insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant 2011; 11: 1563-1569.
4. Shen X, Wang Y, Gao F, et al. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury. Hepatology 2009; 50: 1537-1546.
5. Yeung MY, McGrath M, Najafian N., The emerging role of the TIM molecules in transplantation. Am J Transplant 2011; 11: 2012-2019.
6. Uchida Y, Ke B, Freitas MC, et al. The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse. Hepatology 2010; 51: 1363-1372.
7. Zhang Y, Ji H, Shen X, et al. Targeting TIM-1 on CD4 T cells depresses macrophage activation and overcomes ischemia-reperfusion injury in mouse orthotopic liver transplantation. Am J Transplant 2013; 13: 56-66.
8. Rong S, Park JK, Kirsch T, et al. The TIM-1:TIM-4 pathway enhances renal ischemia-reperfusion injury. J Am Soc Nephrol 2011; 22: 484-495.
9. Uchida Y, Ke B, Freitas MC, et al. T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner. Gastroenterology 2010; 139: 2195-2206.
10. Ji H, Shen X, Gao F, et al. Programmed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury. Hepatology 2010; 52: 1380-1389.
11. Shen XD, Gao F, Ke B, et al. Inflammatory responses in a new mouse model of prolonged hepatic cold ischemia followed by arterialized orthotopic liver transplantation. Liver Transpl 2005; 11: 1273-1281.
12. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D., Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993; 55: 1265-1272.
13. Han G, Chen G, Shen B, Li Y., Tim-3: An activation marker and activation limiter of innate immune cells. Front Immunol 2013; 4: 449.
14. Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH., TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev 2010; 235: 172-189.
15. Boenisch O, D'Addio F, Watanabe T, et al. TIM-3: a novel regulatory molecule of alloimmune activation. J Immunol 2010; 185: 5806-5819.
16. Rangachari M, Kuchroo VK., Using EAE to better understand principles of immune function and autoimmune pathology. J Autoimmun 2013; 45: 31-39.
17. Sanchez-Fueyo A, Tian J, Picarella D, et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 2003; 4: 1093-1101.
18. Elahi S, Niki T, Hirashima M, Horton H., Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection. Blood 2012; 119: 4192-4204.
19. Zhou Q, Munger ME, Veenstra RG, et al. Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Blood 2011; 117: 4501-4510.
20. Wang F, Hou H, Xu L, et al. Tim-3 signaling pathway as a novel negative mediator in lipopolysaccharide-induced endotoxic shock. Hum Immunol 2014; 75: 470-478.
21. Gupta S, Thornley TB, Gao W, et al. Allograft rejection is restrained by short-lived TIM-3+ PD-1+ Foxp3+ Tregs. J Clin Invest 2012; 122: 2395-2404.
22. McGrath MM, Najafian N., The role of coinhibitory signaling pathways in transplantation and tolerance. Front Immunol 2012; 3: 47.
23. Golden-Mason L, Palmer BE, Kassam N, et al. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J Virol 2009; 83: 9122-9130.
24. Rabb H, Daniels F, O'Donnell M, et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 2000; 279: F525-F531.
25. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JF., CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997; 100: 279-289.
26. Kuboki S, Sakai N, Tschop J, Edwards MJ, Lentsch AB, Caldwell CC., Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2009; 296: G1054-G1059.
27. Shen XD, Ke B, Zhai Y, et al. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatology 2003; 37: 296-303.
28. Caldwell CC, Tschoep J, Lentsch AB., Lymphocyte function during hepatic ischemia/reperfusion injury. J Leukoc Biol 2007; 82: 457-464.
29. Pommey S, Lu B, McRae J, et al. Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells. Hepatology 2013; 57: 1597-1606.
30. Zhu C, Anderson AC, Schubart A, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005; 6: 1245-1252.
31. Tang ZH, Liang S, Potter J, Jiang X, Mao HQ, Li Z., Tim-3/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease. J Immunol 2013; 190: 1788-1796.
32. He W, Fang Z, Wang F, et al. Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice. Transplantation 2009; 88: 782-790.
33. Shimmura-Tomita M1, Wang M, Taniguchi H, Akiba H, Yagita H, Hori J., Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts. PLoS ONE 2013; 8: e63620. doi: 10.1371/journal.pone.0063620